DSG3 and acquired polycythemia vera: The pathogenesis of PV involves anti-desmoglein (Dsg) antibodies that disrupt the epidermal cell junctions of a protein called desmoglein 3 (Dsg3), leading to clinical manifestations such as blisters and maculopapular rash [86].